Syphilis patients may be most affected by penicillin shortage
Pfizer’s “unanticipated manufacturing delay” involving the recommended treatment for syphilis will pose problems for the growing number of patients with the sexually transmitted infection.
For more on the CDC’s efforts to prioritize available penicillin for syphilis patients, click on the link below:
John Gregory, Senior Writer
John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.